Blood test trial seeks faster answers for tough cancers

NCT ID NCT06290856

Summary

This study aimed to see if simple blood tests could help doctors make better treatment decisions for people with advanced pancreatic, bile duct, or colorectal cancers. Researchers wanted to check if these 'liquid biopsies' could identify the right patients for specific drugs or track when treatments stop working. The trial was stopped early after enrolling 16 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Oslo university Hospital

    Oslo, Norway

Conditions

Explore the condition pages connected to this study.